Dr. Karls is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
650 1st Ave
3rd Floor
New York, NY 10016Phone+1 212-261-6902
Education & Training
- McGill University Faculty of MedicineClass of 2012
- Concordia UniversityBS, Biology, With great distinction, 2005 - 2008
- Marianopolis CollegeDiploma, College Studies, Health Science, 2003 - 2005
Certifications & Licensure
- NY State Medical License 2018 - 2021
- MA State Medical License 2017 - 2018
- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- Garnett Key Society nominee Concordia University, 2008
- Deans honor list - Medicine year 1 McGill University, 2008
- Golden Key Honor Society (lifetime membership) Concordia University, 2007
- Join now to see all
Publications & Presentations
PubMed
- Axumin (F-Fluciclovine) PET imaging in men exhibiting no clinically significant cancer on initial negative biopsy of PI-RADS 4 and 5 regions of interest.Ezequiel Becher, Shawn Karls, Angela Tong, James S Wysock, Samir S Taneja
World Journal of Urology. 2022-11-01 - 2 citationsCorrelation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasmsShawn Karls, Richard Gold, Sasha Kravets, Yating Wang, Su-Chun Cheng
Annals of Nuclear Medicine. 2021-06-19 - 1 citations18F-Fluciclovine Uptake in Thymoma Demonstrated on PET/MRI.Lucas Tsikitas, Shawn Karls, Anca-Oana Kranz, Kent Friedman, Sonia Mahajan
Clinical Nuclear Medicine. 2021-03-01
Journal Articles
- PET/CT for Lymphoma Post-Therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant and Lymphoma Follow-upShawn Karls, Hina Shah, Heather Jacene, Semin Nucl Med, 1/1/2018
- Interrupted Iodine-131 Procedures for Patients with Differentiated Thyroid Cancer: Comparing Thyroxine Withdrawal with Recombinant Thyrotropin Preparation TechniquesShawn Karls, Gad Abikhzer, Michael Tamilia, Stephan Probst, Clin Nucl Med, 1/1/2017
- Nuclear Imaging in a Cardiac ParagangliomaNada Almenieir, Shawn Karls, Robert Lisbona, Vilma Derbekyan, J Nucl Med Technol, 1/1/2017
- Join now to see all
Abstracts/Posters
- Gender as a Risk Factor of Malignancy in a Thyroid NoduleShawn Karls, Alex Amir, Noah Sands, Michael Tamilia, Michael Hier, Martin Black, Juan Rivera, Olga Gologan, and Richard Payne, American Academy of Otolaryngology - Head and Neck Surgery annual meeting, Boston, MA, 1/1/2010
- Is Gender a Risk Factor of Thyroid Cancer in Patients Presenting with a Palpable Thyroid Nodule?Shawn Karls, Alex Amir, Michael P. Hier, Martin J. Black, Michael Tamilia, Juan Rivera, Olga Gologan, and Richard J. Payne, Canadian Society of Otolaryngology - Head and Neck Surgery - Annual meeting, Niagara Falls, ON, 1/1/2010
- Thyroglobulin as a Marker for Thyroid Cancer.Shawn Karls, Noah Sands, Michael Tamilia, Juan Rivera, Olga Gologan, Martin Black, and Richard Payne, World Congress on Thyroid Cancer, Toronto, ON, 1/1/2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: